189 related articles for article (PubMed ID: 19353248)
1. Oral tolerization with cardiac myosin peptide (614-629) ameliorates experimental autoimmune myocarditis: role of STAT 6 genes in BALB/CJ mice.
Gonnella PA; Del Nido PJ; McGowan FX
J Clin Immunol; 2009 Jul; 29(4):434-43. PubMed ID: 19353248
[TBL] [Abstract][Full Text] [Related]
2. Myosin-primed tolerogenic dendritic cells ameliorate experimental autoimmune myocarditis.
Lee JH; Kim TH; Park HE; Lee EG; Jung NC; Song JY; Seo HG; Seung KB; Chang K; Lim DS
Cardiovasc Res; 2014 Feb; 101(2):203-10. PubMed ID: 24189626
[TBL] [Abstract][Full Text] [Related]
3. Autoimmune myocarditis.
Smith SC
Curr Protoc Immunol; 2001 May; Chapter 15():Unit 15.14. PubMed ID: 18432731
[TBL] [Abstract][Full Text] [Related]
4. Recombinant cardiac myosin fragment induces experimental autoimmune myocarditis via activation of Th1 and Th17 immunity.
Daniels MD; Hyland KV; Wang K; Engman DM
Autoimmunity; 2008 Sep; 41(6):490-9. PubMed ID: 18781477
[TBL] [Abstract][Full Text] [Related]
5. Protection against experimental autoimmune myocarditis is mediated by interleukin-10-producing T cells that are controlled by dendritic cells.
Li Y; Heuser JS; Kosanke SD; Hemric M; Cunningham MW
Am J Pathol; 2005 Jul; 167(1):5-15. PubMed ID: 15972947
[TBL] [Abstract][Full Text] [Related]
6. STAT4 silencing underlies a novel inhibitory role of microRNA-141-3p in inflammation response of mice with experimental autoimmune myocarditis.
Pan A; Tan Y; Wang Z; Xu G
Am J Physiol Heart Circ Physiol; 2019 Sep; 317(3):H531-H540. PubMed ID: 31225989
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-12 receptor/STAT4 signaling is required for the development of autoimmune myocarditis in mice by an interferon-gamma-independent pathway.
Afanasyeva M; Wang Y; Kaya Z; Stafford EA; Dohmen KM; Sadighi Akha AA; Rose NR
Circulation; 2001 Dec; 104(25):3145-51. PubMed ID: 11748115
[TBL] [Abstract][Full Text] [Related]
8. Experimental autoimmune myocarditis in A/J mice is an interleukin-4-dependent disease with a Th2 phenotype.
Afanasyeva M; Wang Y; Kaya Z; Park S; Zilliox MJ; Schofield BH; Hill SL; Rose NR
Am J Pathol; 2001 Jul; 159(1):193-203. PubMed ID: 11438466
[TBL] [Abstract][Full Text] [Related]
9. Myosin autoimmunity is not essential for cardiac inflammation in acute Chagas' disease.
Leon JS; Wang K; Engman DM
J Immunol; 2003 Oct; 171(8):4271-7. PubMed ID: 14530351
[TBL] [Abstract][Full Text] [Related]
10. Galectin-3 deficiency enhances type 2 immune cell-mediated myocarditis in mice.
Kovacevic MM; Pejnovic N; Mitrovic S; Jovicic N; Petrovic I; Arsenijevic N; Lukic ML; Ljujic B
Immunol Res; 2018 Aug; 66(4):491-502. PubMed ID: 30099675
[TBL] [Abstract][Full Text] [Related]
11. Pitavastatin regulates helper T-cell differentiation and ameliorates autoimmune myocarditis in mice.
Tajiri K; Shimojo N; Sakai S; Machino-Ohtsuka T; Imanaka-Yoshida K; Hiroe M; Tsujimura Y; Kimura T; Sato A; Yasutomi Y; Aonuma K
Cardiovasc Drugs Ther; 2013 Oct; 27(5):413-24. PubMed ID: 23722419
[TBL] [Abstract][Full Text] [Related]
12. Complete Freund's adjuvant induces experimental autoimmune myocarditis by enhancing IL-6 production during initiation of the immune response.
Fontes JA; Barin JG; Talor MV; Stickel N; Schaub J; Rose NR; Čiháková D
Immun Inflamm Dis; 2017 Jun; 5(2):163-176. PubMed ID: 28474508
[TBL] [Abstract][Full Text] [Related]
13. Oleanolic acid modulates the immune-inflammatory response in mice with experimental autoimmune myocarditis and protects from cardiac injury. Therapeutic implications for the human disease.
Martín R; Cordova C; San Román JA; Gutierrez B; Cachofeiro V; Nieto ML
J Mol Cell Cardiol; 2014 Jul; 72():250-62. PubMed ID: 24732212
[TBL] [Abstract][Full Text] [Related]
14. Apigenin Attenuates Experimental Autoimmune Myocarditis by Modulating Th1/Th2 Cytokine Balance in Mice.
Zhang S; Liu X; Sun C; Yang J; Wang L; Liu J; Gong L; Jing Y
Inflammation; 2016 Apr; 39(2):678-86. PubMed ID: 26658748
[TBL] [Abstract][Full Text] [Related]
15. Cutting edge: a critical role for IL-10 in induction of nasal tolerance in experimental autoimmune myocarditis.
Kaya Z; Dohmen KM; Wang Y; Schlichting J; Afanasyeva M; Leuschner F; Rose NR
J Immunol; 2002 Feb; 168(4):1552-6. PubMed ID: 11823481
[TBL] [Abstract][Full Text] [Related]
16. The effect of early and late treatment with the tyrphostin AG-556 on the progression of experimental autoimmune myocarditis.
George J; Barshack I; Goldberg I; Keren P; Gazit A; Levitzki A; Keren G; Roth A
Exp Mol Pathol; 2004 Jun; 76(3):234-41. PubMed ID: 15126106
[TBL] [Abstract][Full Text] [Related]
17. Recombinant murine interleukin-12 facilitates induction of cardiac myosin-specific type 1 helper T cells in rats.
Okura Y; Takeda K; Honda S; Hanawa H; Watanabe H; Kodama M; Izumi T; Aizawa Y; Seki S; Abo T
Circ Res; 1998 Jun; 82(10):1035-42. PubMed ID: 9622156
[TBL] [Abstract][Full Text] [Related]
18. IL-10 gene modified dendritic cells induced antigen-specific tolerance in experimental autoimmune myocarditis.
Yang S; Li W; Liu W; Gao C; Zhou B; Li S; Li Y; Kong Y
Clin Immunol; 2006 Oct; 121(1):63-73. PubMed ID: 16904381
[TBL] [Abstract][Full Text] [Related]
19. Fatal eosinophilic myocarditis develops in the absence of IFN-γ and IL-17A.
Barin JG; Baldeviano GC; Talor MV; Wu L; Ong S; Fairweather D; Bedja D; Stickel NR; Fontes JA; Cardamone AB; Zheng D; Gabrielson KL; Rose NR; Ciháková D
J Immunol; 2013 Oct; 191(8):4038-47. PubMed ID: 24048893
[TBL] [Abstract][Full Text] [Related]
20. GM-CSF promotes inflammatory dendritic cell formation but does not contribute to disease progression in experimental autoimmune myocarditis.
Blyszczuk P; Behnke S; Lüscher TF; Eriksson U; Kania G
Biochim Biophys Acta; 2013 Apr; 1833(4):934-44. PubMed ID: 23103516
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
